Journey Medical Corporation (NASDAQ:DERM) Q1 2022 Earnings Conference Call May 10, 2022 4:30 PM ET

Company Participants

Jose Ibrahim - IR

Claude Maraoui - Co-Founder, President and Chief Executive Officer

Ernie De Paolantonio - Chief Financial Officer

Ramsey Alloush - General Counsel

Conference Call Participants

Kalpit Patel - B. Riley

Brandon Folkes - Cantor Fitzgerald

Scott Henry - ROTH Capital

Operator

Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to the Journey Medical First Quarter 2022 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only-mode. [Operator Instructions] Participants on this call are advised that the audio of the conference call is being broadcast live over the internet and is also being recorded for playback purposes. A webcast replay of the call will be available approximately 1 hour after the end of the call for approximately 30 days. I would now like to turn the conference over to Jose Ibrahim of Co-IR, the company’s Investor Relations firm. Please go ahead, sir.

Jose Ibrahim

Thank you. Good afternoon and thank you everyone for participating in today’s conference call. Joining me today from Journey Medical Corporation’s leadership team are Claude Maraoui, Co-Founder, President and Chief Executive Officer; Ernie De Paolantonio, Chief Financial Officer; and Ramsey Alloush, General Counsel who will be joining for the question-and-answer session.

During this call, management will be making forward-looking statements, including statements that address Journey Medical’s expectations for future performance or operational results. Forward-looking statements involve risks and other factors that may cause actual results to differ materially from those statements. For more information about these risks, please refer to the risk factors described in Journey Medical’s most recently filed periodic reports on Form 10-K and Form 10-Q, the Form 8-K filed with the SEC today and the company’s press release that accompanies this call, particularly the cautionary statements within.

Today’s conference call includes the non-GAAP financial measures and Journey Medical’s beliefs can be useful in evaluating its performance. You should not consider this additional information in isolation or as a substitute for results prepared in accordance with GAAP. For reconciliation of this non-GAAP financial measure to net loss is most direct comparable GAAP financial measure, please see the reconciliation table located in the company’s earnings press release. The contents of this call contain time-sensitive information that’s accurate only as of today May 10, 2022 and except as required by law, Journal Medical disclaims any obligation to publicly update or revise any information to reflect events or circumstances that occur after this call.